Therapeutic strategies and clinical evolution of patients with infantile fibrosarcoma: a unique paediatric case series.
María Dolores Corral SánchezRaquel Jiménez CarrascosoPedro Rubio AparicioDiego Plaza López de SabandoAna Sastre UrgellesJosé Juan Pozo-KreilingerJuan Carlos López GutiérrezJuan Manuel Gómez CervantesEduardo José Ortiz CruzPérez-Martínez AntonioPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Our case series supports that larotrectinib may be a therapeutic option for newborn and infant patients with infantile fibrosarcoma, especially in uncommon locations.
Keyphrases